| Literature DB >> 3622313 |
N Rehnqvist, G Nyberg, P Carlens, E Lindström, T Lundman, R Nordlander, G Ulvenstam, A Aberg, H Aström.
Abstract
This article reviews the results of double-blind comparative studies on the therapeutic use of isosorbide 5-mononitrate as monotherapy in the prophylaxis of angina pectoris. Isosorbide 5-mononitrate appears at least as effective as the same dosage of isosorbide dinitrate and is probably superior to the calcium antagonists. Recent data have shown that isosorbide 5-mononitrate in a controlled-release formulation given once daily has a significantly better antianginal effect than placebo without inducing the development of tolerance.Entities:
Mesh:
Substances:
Year: 1987 PMID: 3622313 DOI: 10.2165/00003495-198700334-00018
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546